Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides - PubMed (original) (raw)
G K Gouras, J P Greenfield, B Vincent, J Naslund, L Mazzarelli, G Fried, J N Jovanovic, M Seeger, N R Relkin, F Liao, F Checler, J D Buxbaum, B T Chait, G Thinakaran, S S Sisodia, R Wang, P Greengard, S Gandy
Affiliations
- PMID: 9546791
- DOI: 10.1038/nm0498-447
Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides
H Xu et al. Nat Med. 1998 Apr.
Abstract
Alzheimer's disease (AD) is characterized by the accumulation of cerebral plaques composed of 40- and 42-amino acid beta-amyloid (Abeta) peptides, and autosomal dominant forms of AD appear to cause disease by promoting brain Abeta accumulation. Recent studies indicate that postmenopausal estrogen replacement therapy may prevent or delay the onset of AD. Here we present evidence that physiological levels of 17beta-estradiol reduce the generation of Abeta by neuroblastoma cells and by primary cultures of rat, mouse and human embryonic cerebrocortical neurons. These results suggest a mechanism by which estrogen replacement therapy can delay or prevent AD.
Similar articles
- Neuronal expression of beta-amyloid precursor protein Alzheimer mutations causes intracellular accumulation of a C-terminal fragment containing both the amyloid beta and cytoplasmic domains.
McPhie DL, Lee RK, Eckman CB, Olstein DH, Durham SP, Yager D, Younkin SG, Wurtman RJ, Neve RL. McPhie DL, et al. J Biol Chem. 1997 Oct 3;272(40):24743-6. doi: 10.1074/jbc.272.40.24743. J Biol Chem. 1997. PMID: 9312066 - Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism.
Gandy S, Petanceska S. Gandy S, et al. Biochim Biophys Acta. 2000 Jul 26;1502(1):44-52. doi: 10.1016/s0925-4439(00)00031-4. Biochim Biophys Acta. 2000. PMID: 10899430 Review. - Estrogens influence growth, maturation, and amyloid beta-peptide production in neuroblastoma cells and in a beta-APP transfected kidney 293 cell line.
Chang D, Kwan J, Timiras PS. Chang D, et al. Adv Exp Med Biol. 1997;429:261-71. doi: 10.1007/978-1-4757-9551-6_19. Adv Exp Med Biol. 1997. PMID: 9413580 - Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain.
Petanceska SS, Nagy V, Frail D, Gandy S. Petanceska SS, et al. Neurology. 2000 Jun 27;54(12):2212-7. doi: 10.1212/wnl.54.12.2212. Neurology. 2000. PMID: 10881241 - Alzheimer's disease.
De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. De-Paula VJ, et al. Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
- Higher rates of decline for women and apolipoprotein E epsilon4 carriers.
Holland D, Desikan RS, Dale AM, McEvoy LK; Alzheimer's Disease Neuroimaging Initiative. Holland D, et al. AJNR Am J Neuroradiol. 2013 Dec;34(12):2287-93. doi: 10.3174/ajnr.A3601. Epub 2013 Jul 4. AJNR Am J Neuroradiol. 2013. PMID: 23828104 Free PMC article. - Regulation of Alzheimer's disease amyloid-beta formation by casein kinase I.
Flajolet M, He G, Heiman M, Lin A, Nairn AC, Greengard P. Flajolet M, et al. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4159-64. doi: 10.1073/pnas.0611236104. Epub 2007 Feb 27. Proc Natl Acad Sci U S A. 2007. PMID: 17360493 Free PMC article. - Ovarian Cycle Stages Modulate Alzheimer-Related Cognitive and Brain Network Alterations in Female Mice.
Broestl L, Worden K, Moreno AJ, Davis EJ, Wang D, Garay B, Singh T, Verret L, Palop JJ, Dubal DB. Broestl L, et al. eNeuro. 2018 Dec 14;5(6):ENEURO.0132-17.2018. doi: 10.1523/ENEURO.0132-17.2018. eCollection 2018 Nov-Dec. eNeuro. 2018. PMID: 30627643 Free PMC article. - Suppression of cyclin-dependent kinase 5 activation by amyloid precursor protein: a novel excitoprotective mechanism involving modulation of tau phosphorylation.
Han P, Dou F, Li F, Zhang X, Zhang YW, Zheng H, Lipton SA, Xu H, Liao FF. Han P, et al. J Neurosci. 2005 Dec 14;25(50):11542-52. doi: 10.1523/JNEUROSCI.3831-05.2005. J Neurosci. 2005. PMID: 16354912 Free PMC article. - Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4.
Pollen DA, Baker S, Hinerfeld D, Swearer J, Evans BA, Evans JE, Caselli R, Rogaeva E, St George-Hyslop P, Moonis M. Pollen DA, et al. Alzheimers Res Ther. 2010 Oct 29;2(5):31. doi: 10.1186/alzrt55. Alzheimers Res Ther. 2010. PMID: 21062519 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources